Depression in Chronic Airways Diseases
Primary Purpose
Chronic Lung Disease
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
hospital anxiety and depression scale
Sponsored by
About this trial
This is an interventional screening trial for Chronic Lung Disease
Eligibility Criteria
Inclusion Criteria:
- Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis
Exclusion Criteria:
- Diabetes Mellitus and Hypertension.
- Cardiac diseases.
- Chronic renal and liver diseases.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
chronic lung diseases
Arm Description
bronchiectasis , bronchial asthma and chronic obstructive pulmonary disease assess anxiety and depression by hospital anxiety and depression scale
Outcomes
Primary Outcome Measures
compare anxiety and depression in different forms of chronic lung diseases
by hospital anxiety and depression scale
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03180164
Brief Title
Depression in Chronic Airways Diseases
Official Title
Anxiety and Depression in Chronic Airways Diseases
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Unknown status
Study Start Date
October 2018 (Anticipated)
Primary Completion Date
October 2019 (Anticipated)
Study Completion Date
October 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Chronic airways diseases involve alterations in the person's social roles, relationships and self-perception so demands continual psychological adjustment .
Also Kunik studied patients with chronic breathing disorders for depression and anxiety and found that 65% of patients were positive for depression and anxiety.
Shackell found that patients' anxiety and fears of breathlessness and dying extended into the night and were aggravated by feelings of isolation and frustration. One patient reported that they often thought 'am I going to see the next morning?'
Detailed Description
This fear and sense of helplessness can lead to panic and evidence suggests that patients with chronic breathlessness often call for emergency assistance during the night According to GOLD report 2017, anxiety and depression in chronic obstructive pulmonary disease patients are both associated with poor prognosis.
Much of the evidence explored so far relates to chronic obstructive pulmonary disease. While other chronic lung diseases have received less attention In addition to, several studies have been found relationship between asthma and psychological disturbance .One review of literature describes an increased prevalence of psychological co-morbidity in asthmatic adults and another research suggests that anxiety and depression are more common in patients with moderate to severe asthma than in the general population Gift. found significantly greater self-reported depression scores among patients with chronic obstructive pulmonary disease receiving prednisone compared to patients not receiving any steroids.
Interestingly, the psychiatric sequel of steroid treatment are often sudden in onset and appear to generally occur within 2 weeks after steroid introduction
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Lung Disease
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
chronic lung diseases
Arm Type
Other
Arm Description
bronchiectasis , bronchial asthma and chronic obstructive pulmonary disease assess anxiety and depression by hospital anxiety and depression scale
Intervention Type
Other
Intervention Name(s)
hospital anxiety and depression scale
Intervention Description
self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic
Primary Outcome Measure Information:
Title
compare anxiety and depression in different forms of chronic lung diseases
Description
by hospital anxiety and depression scale
Time Frame
10 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis
Exclusion Criteria:
Diabetes Mellitus and Hypertension.
Cardiac diseases.
Chronic renal and liver diseases.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maha Ahmed El-Kholy
Phone
00201096956205
Email
maha_elkholy@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Samiaa Hamdy Sadek
Phone
00201006769597
Email
samiaa_sadek@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Reham Mohamed El-Morshedy
Organizational Affiliation
Assiut University
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Depression in Chronic Airways Diseases
We'll reach out to this number within 24 hrs